PYCR1 and familial pancreatic carcinoma: In this study, FTH1 expression was upregulated in most KRAS-mutant human pancreatic cancer cells and clinical pancreatic cancer tissues, contributing to PDAC progression through positive crosstalk with PYCR1 and promoting proline metabolism dysregulation (Supplementary Fig. 7).